FrancophonIA/ELRC3.0 huggingface dataset:
English: Resistance analysis by week 144 On-therapy genotypes Efavirenz resistance1
Croatian: Liječeni genotipovi Rezistencija na efavirenz1 K103N
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan 600 mg/200 mg/245 mg film-coated tablets efavirenz/emtricitabine/tenofovir disoproxil
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil Mylan 600 mg/200 mg/245 mg filmom obložene tablete efavirenz/emtricitabin/tenofovirdizoproksil
English: CCR5 antagonist Maraviroc/Efavirenz (100 mg b.i.d./600 mg q.d.)
Croatian: Antagonist CCR5 maravirok/efavirenz (100 mg b.i.d./ 600 mg q.d.)
English: How to take Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Croatian: Kako uzimati Efavirenz/emtricitabin/tenofovirdizoproksil Mylan
English: Atazanavir/ritonavir/Emtricitabine
Croatian: atazanavir/ritonavir/emtricitabin
English: AUC: ↓ 27% (↓ 20 to ↓ 33) Cmax: ↓ 20% (↓ 15 to ↓ 24) Cmin: ↓ 35% (↓ 24 to ↓ 44) Efavirenz:
Croatian: AUC: ↓ 27 % (↓ 20 do ↓ 33) Cmax: ↓ 20 % (↓ 15 do ↓ 24) Cmin: ↓ 35 % (↓ 24 do ↓ 44) efavirenz:
English: Rifampicin/Tenofovir disoproxil (600 mg q.d./245 mg q.d.)
Croatian: rifampicin/tenofovirdizoproksil (600 mg q.d./ 245 mg q.d.)
English: Use of Efavirenz/emtricitabine/tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product.
Croatian: Treba izbjegavati primjenu efavirenza/emtricitabina/tenofovirdizoproksila istovremeno s primjenom ili neposredno nakon primjene nefrotoksičnog lijeka.
English: The administration of efavirenz/emtricitabine/tenofovir disoproxil with food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 5.2).
Croatian: Primjenjivanje efavirenza/emtricitabina/tenofovirdizoproksila s hranom može povećati izloženost efavirenzu te može dovesti do povećane učestalosti nuspojava (vidjeti dio 4.4 i 5.2).
English: Lopinavir/ritonavir/Tenofovir disoproxil (400 mg b.i.d./100 mg b.i.d./245 mg q.d.)
Croatian: lopinavir/ritonavir/tenofovirdizoproks il (400 mg b.i.d./ 100 mg b.i.d./ 245 mg q.d.)
English: Methadone: AUC: ↔ Cmax: ↔ Cmin: ↔ Tenofovir: AUC: ↔ Cmax: ↔ Cmin: ↔
Croatian: metadon: AUC: ↔ Cmax: ↔ Cmin: ↔ tenofovir: AUC: ↔ Cmax: ↔ Cmin: ↔
English: Tacrolimus:
Croatian: takrolimus:
English: AUC: ↓ 39% (↓ 27 to ↓ 50) Cmax: ↓ 29% (↓ 15 to ↓ 40) Cmin: ↓ 46% (↓ 31 to ↓ 58) Efavirenz:
Croatian: AUC: ↓ 39 % (↓ 27 do ↓ 50) Cmax: ↓ 29 % (↓ 15 do ↓ 40) Cmin: ↓ 46 % (↓ 31 do ↓ 58) efavirenz:
English: AUC: ↓ 38% (↓ 28 to ↓ 47) Cmax: ↓ 32% (↓ 15 to ↓ 46) Cmin: ↓ 45% (↓ 31 to ↓ 56) Efavirenz:
Croatian: AUC: ↓ 38 % (↓ 28 do ↓ 47) Cmax: ↓ 32 % (↓ 15 do ↓ 46) Cmin: ↓ 45 % (↓ 31 do ↓ 56) efavirenz:
English: If you forget to take Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Croatian: Ako ste zaboravili uzeti Efavirenz/emtricitabin/tenofovirdizoproksil Mylan
English: AUC: ↓ 55% (↓ 48 to ↓ 62) Cmax: ↓ 34% (↓ 21 to ↓ 47) Hydroxybupropion: AUC: ↔
Croatian: AUC: ↓ 55 % (↓ 48 do ↓ 62) Cmax: ↓ 34 % (↓ 21 do ↓ 47) hidroksibupropion:
English: Lopinavir/ritonavir/Emtricitabine
Croatian: lopinavir/ritonavir/emtricitabin
English: Norgestimate/Ethinyloestradiol/ Emtricitabine
Croatian: norgestimat/etinilestradiol/emtricitabi n
English: AUC: ↓ 10% C12h: ↓ 13%
Croatian: C12h: ↓ 13 %
English: If you stop taking Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Croatian: Ako prestanete uzimati Efavirenz/emtricitabin/tenofovirdizoproksil Mylan
English: Cases of acute renal failure after initiation of high dose or multiple non-steroidal anti-inflammatory drugs (NSAIDs) have been reported in patients treated with tenofovir disoproxil and with risk factors for renal dysfunction.
Croatian: Zabilježeni su slučajevi akutnog zatajenja bubrega u bolesnika s čimbenicima rizika za oštećenje funkcije bubrega koji su liječeni tenofovirdizoproksilom nakon uvođenja visokih doza ili više nesteroidnih antiinflamatornih lijekova (NSAIL).
English: Efavirenz/emtricitabine/tenofovir disoproxil has not been studied in patients over the age of 65.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil nije se ispitivao u bolesnika starijih od 65 godina.
English: You can also report side effects directly via the national reporting system listed in Appendix V By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava za prijavu nuspojava: navedenog u Dodatku V.
English: INFORMATION IN BRAILLE Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Efavirenz/emtricitabin/tenofovirdizoproksil Mylan
English: Clarithromycin/Tenofovir disoproxil
Croatian: klaritromicin/tenofovirdizoproksil
English: AUC: ↔*/** (↓ 10% to ↑ 26%) Cmax: ↔*/** (↓ 5% to ↑ 26%) Cmin: ↑ 12%*/** (↓ 16 to ↑ 49) (CYP3A4 induction).
Croatian: AUC: ↔* (↓ 10 % do ↑ 26 %) Cmax: ↔* (↓ 5 % do ↑ 26 %) Cmin: ↑ 12 %*/ ** (↓ 16 do ↑ 49) (indukcija CYP3A4). * U usporedbi s atazanavirom 300 mg/ritonavirom 100 mg q.d. koji se uzima navečer, bez efavirenza.
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan must be taken every day.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil Mylan mora se uzimati svaki dan.
English: The pharmacokinetics of efavirenz/emtricitabine/tenofovir disoproxil have not been studied in HIV infected patients with hepatic impairment.
Croatian: Farmakokinetika efavirenza/emtricitabina/tenofovirdizoproksila nije ispitana u bolesnika inficiranih virusom HIV-a s oštećenjem funkcije jetre.
English: Women of childbearing potential should undergo pregnancy testing before initiation of efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Žene reproduktivne dobi trebaju prije početka terapije efavirenzom/emtricitabinom/tenofovirdizoproksilom obaviti testiranje trudnoće.
English: Co-administration of efavirenz with atazanavir/ritonavir is not recommended.
Croatian: Ne preporučuje se istovremena primjena efavirenza s atazanavirom/ritonavirom.
English: Each Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan film-coated tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (as maleate).
Croatian: Jedna filmom obložena tableta lijeka Efavirenz/emtricitabin/tenofovirdizoproksil Mylan sadržava 600 mg efavirenza, 200 mg emtricitabina i 245 mg tenofovirdizoproksila (u obliku maleata).
English: Methadone/Efavirenz (35-100 mg q.d./600 mg q.d.)
Croatian: OPIOIDI metadon/efavirenz (35 - 100 mg q.d./ 600 mg q.d.)
English: Efavirenz/emtricitabine/tenofovir disoproxil should be administered with caution to patients with mild hepatic impairment (see sections 4.3 and 4.4).
Croatian: Potrebna je pažnja u slučaju davanja efavirenza/emtricitabina/tenofovirdizoproksila bolesnicima s blagim oštećenjem funkcije jetre (vidjeti dio 4.3 i 4.4).
English: Lopinavir/Ritonavir: AUC: ↔
Croatian: lopinavir/ritonavir:
English: Voriconazole/Emtricitabine
Croatian: vorikonazol/emtricitabin
English: When using efavirenz/emtricitabine/enofovir disoproxil with low-dose ritonavir, the possibility of an increase in the incidence of efavirenz-associated
Croatian: Ako se efavirenz/emtricitabin/tenofovirdi zoproksil daje s niskim dozama ritonavira, nužno je uzeti u obzir veću mogućnost pojave štetnih događaja povezanih s efavirenzom zbog moguće farmakodinamičke interakcije.
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan can reduce the amount of statins in your blood.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil Mylan može smanjiti koncentraciju statina u krvi.
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./200 mg q.d./600 mg q.d., all administered with food)
Croatian: atazanavir/ritonavir/efavirenz (400 mg q.d./ 200 mg q.d./ 600 mg q.d., svi se primjenjuju s hranom)
English: You must not take Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan with certain medicines.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil Mylan ne smije se uzimati zajedno s određenim lijekovima.
English: Rosuvastatin/Tenofovir disoproxil
Croatian: rosuvastatin/tenofovirdizoproksil
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan may affect your kidneys.
Croatian: - Efavirenz/emtricitabin/tenofovirdizoproksil Mylan može negativno utjecati na bubrege.
English: Darunavir/ritonavir/Emtricitabine
Croatian: darunavir/ritonavir/emtricitabin
English: Patients with moderate or severe renal impairment require dose interval adjustment of emtricitabine and tenofovir disoproxil that cannot be achieved with the combination tablet (see sections 4.2 and 4.4).
Croatian: U bolesnika s umjerenim ili teškim oštećenjem funkcije bubrega nužno je prilagođavanje intervala doziranja emtricitabina i tenofovirdizoproksila što se ne može postići kombiniranom tabletom (vidjeti dio 4.2 i 4.4).
English: Efavirenz/emtricitabine/tenofovir disoproxil and vigabatrin or gabapentin can be co-administered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i vigabatrin ili gabapentin mogu se primjenjivati istovremeno bez prilgođavanja doze.
English: Antimycobacterials Rifabutin/Efavirenz (300 mg q.d./600 mg q.d.)
Croatian: Antimikobakterici rifabutin/efavirenz (300 mg q.d./ 600 mg q.d.)
English: Use of appropriate antihistamines and/or corticosteroids is recommended when efavirenz/emtricitabine/tenofovir disoproxil is restarted.
Croatian: U slučaju ponovne primjene efavirenza/emtricitabina/tenofovirdizoproksila preporučuje se primjena odgovarajućih antihistaminika i/ili kortikosteroida.
English: Forty-eight week data showed that high levels of virologic suppression, comparable to the original treatment regimen, were maintained in patients who were randomised to change to efavirenz/emtricitabine/tenofovir disoproxil (see Table 4).
Croatian: Podaci za 48 tjedana pokazali su da su kod bolesnika koji su slučajnim odabirom prešli na uzimanje efavirenza/emtricitabina/tenofovirdizoproksila (vidjeti Tablicu 4) zadržane visoke razine virološke supresije, usporedive s prvotnim režimom liječenja.
English: Voriconazole/Efavirenz (200 mg b.i.d./400 mg q.d.)
Croatian: vorikonazol/efavirenz (200 mg b.i.d./ 400 mg q.d.)
English: Prior PI-based regimen (N=34)
Croatian: Prethodni režim temeljen na inhibitorima proteaze (N = 34)
English: Saquinavir/ritonavir/Tenofovir disoproxil
Croatian: sakvinavir/ritonavir/tenofovirdizopro ksil
English: Insufficient data are available to make a dosing recommendation for lopinavir/ritonavir when dosed with efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Nije dostupno dovoljno podataka za određivanje preporuke doze za lopinavir/ritonavir kada se primjenjuje s efavirenzom/emtricitabinom/tenof ovirdizoproksilom.
English: No data are currently available from clinical studies with efavirenz/emtricitabine/tenofovir disoproxil in treatment-naïve patients or in heavily pretreated patients.
Croatian: Trenutačno nema dostupnih podataka iz kliničkih ispitivanja efavirenza/emtricitabina/tenofovirdizoproksila na bolesnicima koji nisu bili prethodno liječeni, kao ni na onima sa značajnim prethodnim liječenjima.
English: Swallow Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan whole with water.
Croatian: Progutajte cijelu tabletu lijeka Efavirenz/emtricitabin/tenofovirdizoproksil Mylan s vodom.
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan is a fixed-dose combination of efavirenz, emtricitabine and tenofovir disoproxil.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil Mylan kombinacija je efavirenza, emtricitabina i tenofovirdizoproksila u fiksnim dozama.
English: Valproic acid/Efavirenz (250 mg b.i.d./600 mg q.d.)
Croatian: valproična kiselina / efavirenz (250 mg b.i.d./ 600 mg q.d.)
English: As a fixed combination, efavirenz/emtricitabine/tenofovir disoproxil should not be administered concomitantly with other medicinal products containing the components, emtricitabine or tenofovir disoproxil.
Croatian: Efavirenz/emtricitabin/tenofovirdizoproksil se, kao fiksna kombinacija, ne smije primjenjivati istovremeno s drugim lijekovima koji sadržavaju sastojke emtricitabin ili tenofovirdizoproksil.
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./100 mg q.d./600 mg q.d., all administered with food)
Croatian: atazanavir/ritonavir/efavirenz (400 mg q.d./ 100 mg q.d./ 600 mg q.d., svi se primjenjuju s hranom)
English: Lopinavir/ritonavir tablets/Efavirenz (400/100 mg b.i.d./600 mg q.d.)
Croatian: tablete lopinavira/ritonavira / efavirenz (400/100 mg b.i.d./ 600 mg q.d.)
English: Sofosbuvir/velpatasvir and sofosbuvir/velpatasvir/voxilaprevir: Co-administration of efavirenz/emtricitabine/tenofovir disoproxil and sofosbuvir/velpatasvir or sofosbuvir/velpatasvir/voxilaprevir is not recommended (see section 4.4 and Table 1).
Croatian: Ne preporučuje se istovremena primjena efavirenza/emtricitabina/tenofovirdizoproksila i sofosbuvira/velpatasvira ili sofosbuvira/velpatasvira/voksilaprevira (vidjeti dio 4.4 i Tablicu 1).
English: Efavirenz/emtricitabine/tenofovir disoproxil and fosamprenavir/ritonavir can be coadministered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i fosamprenavir/ritonavir mogu se uzimati zajedno bez prilagođavanja doze.
English: Insufficient data are available to make a dosing recommendation for saquinavir/ritonavir when dosed with efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Nije dostupno dovoljno podataka za određivanje preporuke doze za sakvinavir/ritonavir kada se primjenjuje s efavirenzom/emtricitabinom/tenof ovirdizoproksilom.
English: TAMs2
Croatian: Dob
English: Insufficient data are available to make a dosing recommendation for indinavir when dosed with efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Nije dostupno dovoljno podataka za određivanje preporuke doze za indinavir ako se on dozira s efavirenzom/emtricitabinom/tenof ovirdizoproksilom.
English: Paroxetine: AUC: ↔ Cmax: ↔ Cmin: ↔ Efavirenz: AUC: ↔ Cmax: ↔ Cmin: ↔
Croatian: paroksetin: AUC: ↔ Cmax: ↔ Cmin: ↔ efavirenz:
English: or sofosbuvir/velpatasvir/voxilaprevir is expected to decrease plasma concentrations of velpatasvir and voxilaprevir.
Croatian: Očekuje se da će istovremena primjena efavirenza/emtricitabina/tenofovir dizoproksila i sofosbuvira/velpatasvira ili sofosbuvira/velpatasvira/voksilap revira smanjiti koncentraciju velpatasvira i voksilaprevira u plazmi.
English: The pharmacokinetics of efavirenz/emtricitabine/tenofovir disoproxil have not been studied in patients with hepatic impairment.
Croatian: Farmakokinetika efavirenza/emtricitabina/tenofovirdizoproksila nije ispitana u bolesnika s oštećenjem funkcije jetre.
English: ANTICONVULSANTS Carbamazepine/Efavirenz (400 mg q.d./600 mg q.d.)
Croatian: ANTIKONVULZIVI karbamazepin/efavirenz (400 mg q.d./ 600 mg q.d.)
English: Your doctor may then conduct blood tests at regular intervals in order to check how well your liver is working (see section 3, If you stop taking Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan).
Croatian: Vaša jetra radi (pogledajte dio 3, Ako prestanete uzimati lijek Efavirenz/emtricitabin/tenofovirdizoproksil Mylan).
English: Cmax: ↑ 38% (competitive inhibition of oxidative metabolism) Co-administration of standard doses of efavirenz and voriconazole is contraindicated (see section 4.3).
Croatian: Istovremena primjena standardnih doza efavirenza i vorikonazola je kontraindicirana (vidjeti dio 4.3).
English: Carbamazepine/Tenofovir disoproxil
Croatian: karbamazepin/tenofovirdizoproksil
English: Mild-to-moderate rash has been reported with the individual components of efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Zabilježen je blag do umjeren osip pri uzimanju pojedinačnih komponenti efavirenza/emtricitabina/tenofovirdizoproksila.
English: Patients with moderate or severe renal impairment require a dose adjustment of emtricitabine and tenofovir disoproxil that cannot be achieved with the combination tablet (see sections 4.2 and 5.2).
Croatian: U bolesnika s umjerenim ili teškim oštećenjem funkcije bubrega nužno je prilagođavanje doziranja tenofovirdizoproksila, što se ne može postići kombiniranom tabletom (vidjeti dio 4.2 i 5.2).
English: Paroxetine/Efavirenz (20 mg q.d./600 mg q.d.)
Croatian: paroksetin/efavirenz (20 mg q.d./ 600 mg q.d.)
English: Clarithromycin/Efavirenz (500 mg b.i.d./400 mg q.d.)
Croatian: Antibiotici klaritromicin/efavirenz (500 mg b.i.d./ 400 mg q.d.)
English: Valproic acid/Tenofovir disoproxil
Croatian: valproična kiselina / tenofovirdizoproksil
English: The following side effects are common (these may affect up to 1 in 10 patients)
Croatian: Sljedeće nuspojave su česte (mogu se pojaviti u do 1 na 10 bolesnika):
English: Co-administration of saquinavir/ritonavir and efavirenz/emtricitabine/tenofovir disoproxil is not recommended.
Croatian: Ne preporučuje se istovremena primjena sakvinavira/ritonavira s efavirenzom/emtricitabinom/tenof ovirdizoproksilom.
English: of antimalarial efficacy, caution is recommended when efavirenz/emtricitabine/tenofovir disoproxil and artemether/lumefantrine tablets are co-administered.
Croatian: Budući da smanjene koncentracije artemetera, dihidroartemisinina ili lumefantrina mogu imati za posljedicu smanjenu antimalarijsku djelotvornost, preporučuje se oprez pri istovremenoj primjeni efavirenza/emtricitabina/tenofovir dizoproksila i artemeter/lumefantrin tableta.
English: Hydroxyitraconazole: AUC: ↓ 37% (↓ 14 to ↓ 55) Cmax: ↓ 35% (↓ 12 to ↓ 52) Cmin: ↓ 43% (↓ 18 to ↓ 60) Efavirenz:
Croatian: AUC: ↓ 37 % (↓ 14 do ↓ 55) Cmax: ↓ 35 % (↓ 12 do ↓ 52) Cmin: ↓ 43 % (↓ 18 do ↓ 60) efavirenz:
English: METHOD AND ROUTE(S) OF ADMINISTRATION Oral use.
Croatian: NAČIN I PUT(EVI) PRIMJENE LIJEKA Kroz usta.
English: Atorvastatin/Tenofovir disoproxil
Croatian: atorvastatin/tenofovirdizoproksil
English: Efavirenz/emtricitabine/tenofovir disoproxil and sofosbuvir can be coadministered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i sofosbuvir mogu se istovremeno primjenjivati bez prilagodbe doziranja.
English: Evening AUC: ↔ Morning Cmax: ↑ 24% (↑ 12 to
Croatian: AUC ujutro: ↑ 18 % (↑ 6 do ↑ 33) AUC navečer: ↔ Cmaxujutro: ↑ 24 % (↑ 12 do ↑ 38) Cmaxnavečer: ↔
English: Pregnancy should be avoided in women receiving efavirenz/emtricitabine/tenofovir disoproxil.
Croatian: Žene koje primaju efavirenz/emtricitabin/tenofovirdizoproksil trebaju izbjegavati trudnoću.
English: Physicians should refer to current HIV treatment guidelines for the optimal management of HIV infection in patients co-infected with HBV.
Croatian: U cilju optimalnog liječenja infekcije HIV-om u bolesnika koji su istovremeno zaraženi virusom HBV-a, liječnici se trebaju pridržavati trenutno važećih smjernica za liječenje HIV-a.
English: Voriconazole/Tenofovir disoproxil
Croatian: vorikonazol/tenofovirdizoproksil
English: Etonogestrel/Tenofovir disoproxil
Croatian: etonogestrel/tenofovirdizoproksil
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (as maleate).
Croatian: Jedna filmom obložena tableta sadržava 600 mg efavirenza, 200 mg emtricitabina i 245 mg tenofovirdizoproksila (u obliku maleata).
English: AUC: ↑ 21% (↑ 10 to ↑ 34) Cmax: ↑ 14% (↑ 4 to ↑ 26) Cmin: ↑ 25% (↑ 7 to ↑ 46) (inhibition of CYP-mediated oxidative metabolism) When efavirenz was given with ritonavir 500 mg or 600 mg twice daily, the combination was not well tolerated (for example, dizziness, nausea, paraesthesia and elevated liver enzymes occurred).
Croatian: AUC: ↑ 21 % (↑ 10 do ↑ 34) Cmax: ↑ 14 % (↑ 4 do ↑ 26) Cmin: ↑ 25 % (↑ 7 do ↑ 46) (inhibicija oksidativnog metabolizma u kojem sudjeluju enzimi CYP)
English: Rifampicin: AUC: ↔ Cmax: ↔ Tenofovir: AUC: ↔ Cmax: ↔
Croatian: rifampicin: AUC: ↔ Cmax: ↔ tenofovir:
English: -0.5% (-3.2% to 2.2%)
Croatian: 98,9% -0,5% (-3,2% do 2,2%)
English: Posaconazole/Tenofovir disoproxil
Croatian: posakonazol/tenofovirdizoproksil
English: Dosage adjustments of simvastatin may be required when co-administered with efavirenz/emtricitabine/tenofovir disoproxil (refer to the Summary of Product Characteristics for simvastatin).
Croatian: Možda će biti potrebno podešavanje doze simvastatina kada se primjenjuje istovremeno s efavirenzom/emtricitabinom/tenof ovirdizoproksilom (pogledajte sažetak opisa svojstava lijeka za simvastatin).
English: Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan contains sodium and lactose This medicine contains 7.5 mg of sodium metabisulfite per tablet, which may rarely cause severe hypersensitivity reactions and bronchospasm.
Croatian: Ovaj lijek sadržava 7,5 mg natrijeva metabisulfita po tableti, što u rijetkim slučajevima može uzrokovati teške reakcije preosjetljivosti i bronhospazam.
English: Efavirenz/emtricitabine/tenofovir disoproxil and raltegravir can be coadministered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i raltegravir mogu se primjenjivati istovremeno bez prilagodbe doze.
English: Efavirenz/emtricitabine/tenofovir disoproxil and valproic acid can be co-administered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i valproična kiselina mogu se primjenjivati istovremeno bez prilgođavanja doze.
English: Symptoms including, but not limited to, dizziness, insomnia, somnolence, impaired concentration and abnormal dreaming are frequently reported undesirable effects in patients receiving efavirenz 600 mg daily in clinical studies.
Croatian: U bolesnika koji su tijekom kliničkih ispitivanja primali 600 mg efavirenza dnevno često su uočene nuspojave koje između ostalog uključuju vrtoglavicu, nesanicu, somnolenciju, smanjenu koncentraciju i abnormalne snove.
English: Co-administration of atazanavir/ritonavir and efavirenz/emtricitabine/tenofovir disoproxil is not recommended.
Croatian: Ne preporučuje se istovremena primjena atazanavira/ritonavira s efavirenzom/emtricitabinom/tenof ovirdizoproksilom.
English: Dosage adjustments of atorvastatin may be required when co-administered with efavirenz/emtricitabine/tenofovir disoproxil (refer to the Summary of Product Characteristics for atorvastatin).
Croatian: Možda će biti potrebno podešavanje doze atorvastatina kada se primjenjuje istovremeno s efavirenzom/emtricitabinom/tenof ovirdizoproksilom (pogledajte sažetak opisa svojstava lijeka za atorvastatin).
English: AUC0-last
Croatian: • svrbež
English: AUC: ↓ 58% (↓ 39 to ↓ 68) Cmax: ↓ 51% (↓ 32 to ↓ 58) Total active HMG Co-A reductase inhibitors:
Croatian: AUC: ↓ 69 % (↓ 62 do ↓ 73) Cmax: ↓ 76 % (↓ 63 do ↓ 79) simvastatin u obliku kiseline: AUC: ↓ 58 % (↓ 39 do ↓ 68) Cmax: ↓ 51 % (↓ 32 do ↓ 58) Ukupni aktivni inhibitori HMG Co-A reduktaze:
English: Sofosbuvir/Velpatasvir/Voxilaprevir (400 mg/100 mg/100 mg q.d.)
Croatian: sofosbuvir/velpatasvir/voksilaprevir (400 mg/100 mg/100 mg q.d.) + efavirenz/emtricitabin/tenofovirdizop roksil (600 mg/200 mg/245 mg q.d.)
English: - If you have any further questions, ask your doctor or pharmacist - This medicine has been prescribed for you only.
Croatian: - Ako imate dodatnih pitanja, obratite se liječniku ili ljekarniku.
English: Efavirenz/emtricitabine/tenofovir disoproxil and paroxetine can be coadministered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i paroksetin mogu se istovremeno primjenjivati bez prilagodbe doziranja.
English: Buprenorphine/naloxone/Emtricitabine Interaction not studied.
Croatian: buprenorfin/nalokson/emtricitabin Interakcija nije ispitana. buprenorfin/nalokson/tenofovirdizopr oksil
English: Concomitant administration of efavirenz/emtricitabine/tenofovir disoproxil and sofosbuvir/velpatasvir
Croatian: Sofosbuvir/velpatasvir i sofosbuvir/velpatasvir/voksilaprevir:
English: No human data on the effect of efavirenz/emtricitabine/tenofovir disoproxil are available.
Croatian: Nema podataka o učinku efavirenza/emtricitabina/tenofovirdizoproksila na plodnost u čovjeka.
English: Efavirenz/emtricitabine/tenofovir disoproxil and fluoxetine can be coadministered without dose adjustment.
Croatian: Efavirenz/emtricitabin/tenofovirdi zoproksil i fluoksetin mogu se istovremeno primjenjivati bez prilagodbe doziranja.